CA961770A - Psychopharmacological preparations containing an octapeptide - Google Patents
Psychopharmacological preparations containing an octapeptideInfo
- Publication number
- CA961770A CA961770A CA122,529A CA122529A CA961770A CA 961770 A CA961770 A CA 961770A CA 122529 A CA122529 A CA 122529A CA 961770 A CA961770 A CA 961770A
- Authority
- CA
- Canada
- Prior art keywords
- psychopharmacological
- octapeptide
- preparations containing
- preparations
- psychopharmacological preparations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000002360 preparation method Methods 0.000 title 1
- 230000001003 psychopharmacologic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/15—Oxytocin or vasopressin; related peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL7014204.A NL167323C (nl) | 1970-09-26 | 1970-09-26 | Werkwijze ter bereiding van een psychofarmacologisch preparaat. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA961770A true CA961770A (en) | 1975-01-28 |
Family
ID=19811171
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA122,529A Expired CA961770A (en) | 1970-09-26 | 1971-09-10 | Psychopharmacological preparations containing an octapeptide |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3743726A (cs) |
| BE (1) | BE773022A (cs) |
| CA (1) | CA961770A (cs) |
| DE (1) | DE2147799C3 (cs) |
| FR (1) | FR2108007B1 (cs) |
| GB (1) | GB1342803A (cs) |
| NL (1) | NL167323C (cs) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2254061A1 (de) * | 1972-11-04 | 1974-05-16 | Hoechst Ag | Lh-releasing hormon zur nasalen applikation |
| DE2254043C2 (de) * | 1972-11-04 | 1985-01-24 | Hoechst Ag, 6230 Frankfurt | LH-Releasing Hormon zur nasalen Applikation |
| JPS53132539A (en) * | 1977-04-22 | 1978-11-18 | Takeda Chem Ind Ltd | Protected amino acid or peptide having said protected amino acid residue |
| FI65914C (fi) * | 1978-03-07 | 1984-08-10 | Sandoz Ag | Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a |
| DK153883A (da) * | 1982-04-20 | 1983-10-21 | Ceskoslovenska Akademie Ved | Vasopressin-analoge |
| CS230315B1 (cs) * | 1982-04-20 | 1984-08-13 | Frantisek Brtnik | Analogy vasopresinu a způsob jejich výroby |
| HU198626B (en) * | 1986-05-27 | 1989-11-28 | Sandoz Ag | Process for producing pharmaceutical compositions comprising somatostatin analogues as active ingredient |
| FR2640137A1 (fr) * | 1988-12-08 | 1990-06-15 | Texinfine Sa | Systemes transporteurs de principes actifs lipophiles et leur procede d'obtention |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL105323C (cs) * | 1900-01-01 |
-
1970
- 1970-09-26 NL NL7014204.A patent/NL167323C/xx not_active IP Right Cessation
-
1971
- 1971-09-10 CA CA122,529A patent/CA961770A/en not_active Expired
- 1971-09-10 US US00179519A patent/US3743726A/en not_active Expired - Lifetime
- 1971-09-14 GB GB4286971A patent/GB1342803A/en not_active Expired
- 1971-09-24 BE BE773022A patent/BE773022A/xx not_active IP Right Cessation
- 1971-09-24 DE DE2147799A patent/DE2147799C3/de not_active Expired
- 1971-09-24 FR FR7134423A patent/FR2108007B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE2147799C3 (de) | 1982-01-14 |
| BE773022A (fr) | 1972-03-24 |
| DE2147799B2 (de) | 1981-02-26 |
| DE2147799A1 (de) | 1972-04-06 |
| NL7014204A (cs) | 1972-03-28 |
| NL167323C (nl) | 1981-12-16 |
| FR2108007B1 (cs) | 1975-12-26 |
| NL167323B (nl) | 1981-07-16 |
| US3743726A (en) | 1973-07-03 |
| GB1342803A (en) | 1974-01-03 |
| FR2108007A1 (cs) | 1972-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1906470A (en) | Harmatinic preparations | |
| CA961770A (en) | Psychopharmacological preparations containing an octapeptide | |
| AU3628971A (en) | New pharmaceutical preparations | |
| AU3504771A (en) | Enzyme preparations | |
| CA935091A (en) | Stable virus preparations | |
| CA984652A (en) | Light-activated diazography | |
| IL37553A0 (en) | Deacylase enzyme preparations | |
| CA918066A (en) | Pharmaceutical preparations | |
| AU1075770A (en) | Therapeutic preparations | |
| AU464325B2 (en) | New pharmaceutical preparations | |
| AU7735181A (en) | Peptide | |
| CA857517A (en) | Terrain-following system | |
| CA858530A (en) | Dental preparations | |
| AU456248B2 (en) | Oral preparations | |
| CA851157A (en) | Disinfectant preparations | |
| AU458023B2 (en) | Pharmaceutical preparations | |
| AU447332B2 (en) | Pharmaceutical preparations | |
| AU454079B2 (en) | Hair preparations | |
| CA845682A (en) | Insulin preparations | |
| CA823177A (en) | Medicament preparations | |
| AU434614B2 (en) | Light-activated diazography | |
| CA807125A (en) | Pharmaceutical preparations containing glucofuranosides | |
| CA834706A (en) | Depilatory preparations | |
| AU2892571A (en) | Oral preparations | |
| AU2932471A (en) | Pharmaceutical preparations |